Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19
Clinical trial NCT04568863 · COMPLETED
Trial details
- NCT number
- NCT04568863
- Sponsor
- Pharmamel S.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-20
- Primary completion
- 2020-11-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.